| 2026-08-10 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-10 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-06-22 | Press release | Press release · Jun 2026 |
| 2026-06-17 | 8-K | Form 8-K, Item 5.02 |
| 2026-06-16 | Press release | Press release · Jun 2026 |
| 2026-06-12 | Transcript | FY26 earnings call transcript |
| 2026-06-11 | Press release | Press release · Jun 2026 |
| 2026-06-09 | Press release | iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress |
| 2026-05-14 | Transcript | Q1 FY26 earnings call transcript |
| 2026-05-13 | Press release | IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization |
| 2026-05-13 | Deck | Q1 Presentation · 2026 |
| 2026-05-13 | Press release | Q1 Shareholder Letter · 2026 |
| 2026-05-13 | 8-K | Form 8-K/A, Item 8.01 |
| 2026-05-13 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-13 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-30 | Document | April 2026 Letter to Shareholders |
| 2026-04-30 | 8-K | Form 8-K, Item 8.01 |
| 2026-04-30 | Proxy | Definitive proxy statement |
| 2026-03-26 | Press release | Press release · Q4 2025 · Mar 2026 |
| 2026-03-26 | Deck | Investor presentation · Q1 2026 · Mar 2026 |
| 2026-03-26 | 8-K | Form 8-K, Item 2.02 results |
| 2026-03-26 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-03-20 | Press release | iMDx to Release Fourth Quarter 2025 Results on and Attend Needham Virtual Healthcare Conference |
| 2026-03-13 | Press release | Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score |
| 2026-03-03 | Press release | Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission |
| 2026-02-26 | 8-K | Form 8-K, Item 1.01 |
| 2026-02-12 | 8-K | Form 8-K, Item 1.01 |
| 2026-02-11 | Press release | iMDx Announces $26.0 Million Registered Direct Offering |
| 2026-02-11 | 8-K | Form 8-K, Item 7.01 |
| 2026-01-13 | Press release | IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring |
| 2026-01-07 | Press release | iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation |
| 2026-01-06 | Press release | iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch |
| 2026-01-05 | Press release | iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion |
| 2025-11-10 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-10 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-02 | 8-K | Form 8-K, Item 5.02 |
| 2025-09-19 | 8-K | Form 8-K, Item 5.02 |
| 2025-09-16 | Deck | Investor presentation · Q3 2025 · Sep 2025 |
| 2025-08-15 | Deck | Investor presentation · Aug 2025 |
| 2025-08-11 | Press release | Press release · Q2 2025 · Aug 2025 |